The Science Behind icoone®: 15 Studies, One Committee

icoone® rests on a 2008 patent, a published literature set of papers, proceedings and lectures hosted openly on icoone.com, a Scientific Committee of 40+ clinicians, and outcome figures from i-Tech Industries clinical evaluations. i-Tech cites 15+ scientific studies in total. Here is what is actually in that body of work and how to use it in a buying decision.

Where does the technology come from?

A single patent. Dr. Gianfranco Tudico, CEO of I-Tech Industries in Bologna, patented Roboderm® in 2008. It delivers Multi Micro Alveolar Stimulation — up to 21,600 microstimulations per minute across a microstimulator surface that is 86% micro-holes. The design premise came from anatomy: Prof. Jean-Claude Guimberteau’s work on the microvacuolar structure of connective tissue describes the microvacuole as the functional unit of subcutaneous tissue, and i-Tech built a stimulation pattern scaled to that unit rather than to a hand or a cup. Nearly two decades later, every icoone® configuration still runs that one engine — the mechanism is explained in the Roboderm® guide.

What is in the published literature?

The following are published as open PDFs by i-Tech Industries on icoone.com. A buyer can read them directly, which is a materially different position from being handed a one-page summary.

Foundational anatomy

• The sliding mechanics of the subcutaneous structures in man — illustration of a functional unit: the microvacuoles — Prof. Jean-Claude Guimberteau

Multi Micro Alveolar Stimulation

• Micro Multi Alveolar Stimulation in mechanised connective tissue massage according to the theory of the microvacuole — Prof. Maullu, Prof. Scuderi
• Stroma and its cosmetic functional reactivation — Multi Micro Alveolar Stimulation, a revolution in evolution — Prof. Maullu, Prof. Palmieri
• A new technology for connective tissue micro alveolar stimulation: icoone®-H — Prof. Palmieri
• Scientific study 2019 — Prof. Palmieri

Clinical trial work

• Randomised clinical trial on patients’ compliance and the ergonomics of two devices for mechanized massage — Prof. Scuderi

icooneTalks Scientific Series (2021)

• icooneTalks — Dr. Sorbellini
• icooneTalks — Prof. Saggini
• icooneTalks — Jocelyne Rolland, physiotherapist

Scientific Meeting proceedings

• Proceedings I · Proceedings II · Proceedings III — i-Tech Scientific Committee

Technical reference

• i-Tech Industries technical brochure (2021)

Additional papers in i-Tech’s 15+ set sit outside the cosmetic aesthetic scope of this site and are available from the manufacturer on request.

What is the Scientific Committee?

A standing body of 40+ clinicians convened by i-Tech Industries. Its function is visible in the material above: the Scientific Meeting proceedings are its output, and the icooneTalks series is how that work reaches practitioners. For a buyer, the committee matters less as a credential than as an indicator of continuity — a device company that has been convening clinicians and publishing proceedings for years is running a different operation from one that commissioned a single white paper before launch.

What outcome figures does i-Tech report?

These are manufacturer figures from i-Tech Industries clinical evaluations. Cite them with that attribution, keep “up to” where it appears, and note that individual results vary.

Figure	What i-Tech reports
up to 79%	faster cytokine clearance after the first session
+15%	improvement in skin elasticity
+77%	increase in microvascularization and tissue oxygenation (Biomeca)
−20%	reduction in tissue inflammation
up to 79%	reduction in wrinkle visibility
94%	client satisfaction across clinical evaluations

Alongside those, i-Tech reports a scale figure that is its own kind of evidence: 7,000+ centers in 40+ countries, 6M+ sessions a year and 800,000+ clients. In the United States the number is fewer than 100 devices — which is the commercial opportunity and the reason territory conversations happen early with DNA Distribution.

What does “a decade of evaluations” actually mean here?

Look at the dates on the material. The patent is 2008. The Guimberteau anatomy work and the Maullu/Scuderi MMAS paper form the theoretical base. Palmieri’s icoone®-H technology paper and the 2019 study extend it to a specific hardware generation. The three Scientific Meeting proceedings and the 2021 icooneTalks lectures — Sorbellini, Saggini, Rolland — are the ongoing practitioner-facing series. The 2021 technical brochure documents the hardware as sold.

That sequence is what a durable evidence base looks like: an anatomical premise, a mechanism paper, device-specific work, then years of proceedings. It is worth contrasting with the more common pattern in aesthetic devices, where the entire published record is a single sponsored study timed to a launch. Neither pattern proves a result on your client — but one tells you the manufacturer has been under academic scrutiny for years, and the other does not.

How does the literature relate to what I can claim?

It does not extend it. Published research and regulatory clearance are separate facts. Two icoone® configurations carry a 510(k): Laser Beauty under K182453 and Laser-Med under K211272, each for four labeled indications — relief of minor muscle aches and pain; relief of muscle spasms; temporary improvement of local blood circulation; temporary reduction in the appearance of cellulite. The non-laser Beauty and Medical configurations and the Microfacial carry no FDA wording. All icoone® devices are CE marked and manufactured under ISO 13485. The full map is in the scope guide.

Used correctly, the literature does something a claim cannot: it lets a prospective client — or a sceptical practice partner — read the primary source. In a category where most competing platforms offer a brochure and a testimonial, “here is the paper, here is the patent year, here is the committee” is a stronger position than any percentage.

How should a buyer use this in diligence?

Read the Guimberteau paper first; it explains why the device is shaped the way it is. Read the Scuderi randomised trial second, because compliance and ergonomics are the practical variables that decide whether your therapists and clients stay with a modality. Then read the technical brochure for the hardware. Twenty minutes of primary reading will tell you more than an hour of vendor conversation.

Then move to the commercial side: the configuration guide for which of the five models fits, icoone® cost for the $58,000–$89,000 range and monthly figures of ≈ $1,269 to ≈ $1,948 on a 60-month term at $0 down for qualified buyers (subject to applicant and provider approval), financing for terms, training for what is included, and the 90-Day Launch Program for the first 90 days of demand. Or start at the icoone® hub and the aesthetic range.